Previous Article | Next Article ![]()
Journal of Clinical Microbiology, May 2001, p. 1952-1955, Vol. 39, No. 5
Departments of Medical
Microbiology,1 Internal
Medicine,2 and Clinical
Pathology,3 Maastricht University Hospital,
Maastricht, The Netherlands, and Scientific Institute of Public
Health Louis Pasteur, Brussels, Belgium4
Received 25 September 2000/Returned for modification 22 November
2000/Accepted 26 January 2001
We report on a case of phaeohyphomycosis caused by Alternaria
infectoria in a renal transplant recipient with pulmonary
infiltrates and multiple skin lesions. Diagnosis was based on
microscopy and culture of the skin lesions. Treatment consisted of a
combination of surgical excision and systemic antifungal therapy, first
with itraconazole and subsequently with liposomal amphotericin B, for 39 days. At a 20-month follow-up visit, no recurrence of the skin lesions or the pulmonary infiltrates had occurred.
Phaeohyphomycosis refers to a
subcutaneous and systemic infection caused by dark-walled hyphae in
culture and often in tissue (11). Agents that cause this
infection are primarily recognized as soil saprophytes, plant
pathogens, and contaminants living in the environment. With the growing
number of patients who are immunocompromised, phaeohyphomycotic agents
are increasingly being reported as the cause of human disease
(14, 16). More than 100 species belonging to at least 57 genera are known to be agents of phaeohyphomycosis (17).
Of these species, many have been reported only anecdotally, while
others, such as Bipolaris, Curvularia, Exserohilum, and
Alternaria species, have frequently been involved in human
infections (20, 25). Among the members of the last genus,
the most common species is Alternaria alternata. We report here on an immunocompromised patient with a documented
phaeohyphomycosis caused by Alternaria infectoria, which has
rarely been reported as a human pathogen before. The case presented
here reflects yet an additional example of the growing number of fungi
capable of eliciting phaeohyphomycosis in immunocompromised individuals.
Case report.
A 60-year-old male patient with end-stage renal
disease due to diabetic nephropathy underwent a cadaveric kidney
transplantation. The postoperative course was uneventful, and the
patient was discharged 25 days after transplantation. Five months after
transplantation he presented at the outpatient department with a
painless skin lesion on the right thumb. The patient did not recall any
local skin trauma since the transplantation. On the suspicion of
Kaposi's sarcoma, a punch biopsy specimen was taken from the lesion
for histological examination and the patient was sent home. Three days
later he developed a painful red swelling on his right foot. He also
suffered from a nonproductive cough. No dyspnea or fever was present.
Routine laboratory tests revealed a leukocyte count of
9,300/mm3 and a hemoglobin level of 6.8 mmol/liter. His
serum creatinine level was stable (133 µmol/liter). Chest X ray
revealed in the right and left lower lobes pulmonary infiltrates that
had been absent 5 months previously. The patient was admitted for
further evaluation.
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.5.1952-1955.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Phaeohyphomycosis Caused by Alternaria
infectoria in a Renal Transplant Recipient
![]()
ABSTRACT
Top
Abstract
Text
References
![]()
TEXT
Top
Abstract
Text
References
|
|
Mycological findings. Grocott-Gomori methenamine silver nitrate staining of touch preparations of a biopsy specimen from the right foot obtained on the day of admission showed smooth, branched hyphae. Biopsy specimens from the same lesion initially cultured in Sabouraud broth at 35°C yielded mycelial growth after 4 days of incubation and were subsequently cultured on Sabouraud agar at room temperature. After approximately 7 days, brown woolly colonies were seen. Examination of lactophenol preparations of these colonies showed conidia and septate hyphae. Conidia were avoid, smooth walled, or verrucose; some of them were muriform and often ended with apical beaks. The strain was initially identified as an Alternaria species, and a subculture was sent to the Scientific Institute of Public Health Louis Pasteur, Brussels, Belgium, for species identification.
Specimens from the subculture were inoculated onto malt extract agar for incubation at 25 and 35°C. After 7 days, scant growth was noted at 35°C. The samples incubated at 25°C showed readily sporulating olivaceous-black colonies with diameters of up to 5 cm. Conidiophores were dark, septate, simple, or geniculate. Conidia were ovoid or ellipsoidal, mostly 10 to 44 by 8 to 11 µm, and smooth walled or verrucose; some had one or more transverse and sometimes longitudinal or oblique septa. Some, mostly young, conidia showed apical growth of long, geniculate, secondary conidiophores (pseudorostrata) (Fig. 3a). Chains of a few conidia separated by secondary conidiophores were also seen (Fig. 3b). On the basis of the last two characteristics, the species was identified as A. infectoria (22, 23). The strain is preserved at the IHEM Culture Collection (IHEM 16110), and its identification was confirmed by the Institute of the Royal Netherlands Academy of Arts and Sciences (Centraalbureau voor Schimmelcultures), Baarn, The Netherlands.
|
Discussion. Phaeohyphomycosis is a fungal infection caused by dematiaceous or darkly pigmented fungi (1). Among other mycoses, this fungal infection is increasingly seen in immunocompromised patients (25). Clinical manifestations may range from local skin lesions to invasive and disseminated infections (13).
Diagnosis is made by histopathological examination of tissue specimens. The early histopathologic picture is one of multiple stellate abscesses, which progress to a single circumscribed lesion with a central cavity filled with pus and surrounded by a fibrous wall (26). The margins of these abscesses and the granulomas are composed of giant cells, epithelioid cells, histiocytes, plasma cells, and lymphocytes; fungi are found in or adjacent to purulent areas (11). Despite the dematiaceous nature of the fungi, the brown pigment is not always apparent (13) and hyphae may appear hyaline in lesions when hematoxylin-eosin stain is used (15), such as was seen in our patient's specimen (Fig. 2, top panel); in contrast, the natural brown color of the hyphae is masked by the Grocott staining method. Therefore, confirmation of the presence of a dematiaceous mold can be achieved by using a melanin-specific stain, such as the Fontana-Masson stain (Fig. 2, bottom panels) (7). More than 100 fungal species have been documented as agents of phaeohyphomycosis (17). The genera most frequently involved in human infections include Bipolaris, Curvularia, Exserohilum, and Alternaria (20, 25). Among the members of the last genus, the most commonly found species is A. alternata (4). In this report we describe a case of phaeohyphomycosis caused by A. infectoria. The microscopic characteristics typical of A. infectoria include the presence of prominent pseudorostrata (secondary conidiophores) (Fig. 3a) and chains of conidia separated by secondary conidiophores (Fig. 3b) (5, 24). A. infectoria has been found to cause cutaneous lesions in a cat (18) and, to our knowledge, has previously been reported as a human pathogen in only two cases. Laumaillé et al. (12) have described a cutaneous lesion caused by A. infectoria in a liver transplant recipient. Treatment consisted of a total resection without antifungal agents; however, recurrence of the lesion was noted 5 months later. In the second case, Alternaria infection presented as sinusitis and maxillary osteomyelitis in an otherwise healthy woman. (J. Garau, R. D. Diamond, L. B. Lagrotteria, and S. A. Kabins, Letter, Ann. Intern. Med. 86:747-748, 1977). Culture of a biopsy specimen grew a fungus that was identified as the Alternaria state of Pleospora infectoria (6). Surgical excision of the lesion was performed after a 7-week course of treatment with amphotericin B, but recurrence occurred 4 months later, and prolonged administration of amphotericin B was needed. In our patient described here, the diagnosis of phaeohyphomycosis was confirmed by both microscopic and cultural evidence. The presence of microscopically confirmed lesions on three noncontiguous body sites (right thumb, right foot, left foot) strongly suggests that the disease was disseminated. Although the fungi could not be detected in the BAL fluid samples, we assume that a coexistent pulmonary phaeohyphomycosis was responsible for the pulmonary infiltrates, since the abnormalities noted on chest X ray normalized after the initiation of antifungal therapy. In addition, the pulmonary infiltrates could not be explained by fluid retention since no signs of heart failure were present at the time of presentation. Treatment of phaeohyphomycosis should include complete surgical excision of accessible lesions combined with antifungal therapy, especially when invasive or systemic infection is present (17). The patient described here was successfully treated with a combination of surgery and systemic antifungal therapy. Itraconazole has been found to be as effective as amphotericin B in patients with phaeohyphomycosis (including those with skin and organ involvement), ac-counting for approximately 65% of successful outcomes (21). In our patient, however, the clinical effectiveness of itraconazole remained unclear. Itraconazole therapy was prematurely interrupted because of the development of fluid retention and dyspnea, which were considered adverse effects (19). Possible interaction with felodipine may also have contributed to the development of fluid retention (10). Since amphotericin B is nephrotoxic, the liposomal formulation of this agent was given. This treatment resulted in clinical and histological improvements. In summary, this report presents the third case of human phaeohyphomycosis caused by A. infectoria. Diagnosis was based on cultural and histological examination of cutaneous lesions. The simultaneous presence of multiple skin lesions and pulmonary infiltrates which responded to effective antifungal therapy strongly suggest a disseminated infection. Therapy consisted of surgical excision of the lesions in combination with itraconazole and amphotericin B. We conclude that A. infectoria should be considered in the differential diagnosis of cutaneous and deep-seated phaeohyphomycosis.| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Maastricht University Hospital, P.B. 5800, 6202 AZ, Maastricht, The Netherlands. Phone: 31-43-3874644. Fax: 31-43-3876643. E-mail: AHAL{at}LMIB.AZM.NL.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Ajello, L. 1981. The gamut of human infections caused by dematiaceous fungi. Jpn. J. Med. Mycol. 22:1-5. |
| 2. | Allison, A. C., and E. M. Eugui. 2000. Mycophenolate mofetil and its mechanisms of action. Immunopharmacology 47:85-118[CrossRef][Medline]. |
| 3. |
Almawi, W. S., and O. K. Melemedjian.
2000.
Clinical and mechanistic differences between FK506 (tacrolimus) and cyclosporin A.
Nephrol. Dial. Transplant.
15:1916-1918 |
| 4. | Anaissie, E. J., G. P. Bodey, and M. G. Rinaldi. 1989. Emerging fungal pathogens. Eur. J. Clin. Microbiol. Infect. Dis. 8:323-330[CrossRef][Medline]. |
| 5. | Andersen, B., and U. Thrane. 1996. Differentiation of Alternaria infectoria and Alternaria alternata based on morphology, metabolite profiles, and cultural characteristics. Can. J. Microbiol. 42:685-689. |
| 6. | De Hoog, R. D., and J. Guarro. 1995. Atlas of clinical fungi. Centraalbureau voor Schimmelcultures, Baarn, The Netherlands. |
| 7. | Fothergill, A. W. 1996. Identification of dematiaceous fungi and their role in human disease. Clin. Infect. Dis. 22:S179-S184. |
| 8. |
Jacobs, J. A.,
E. I. De Brauwer,
E. I. Cornelissen, and M. Drent.
2000.
Accuracy and precision of quantitative calibrated loops in transfer of bronchoalveolar lavage fluid.
J. Clin. Microbiol.
38:2117-2121 |
| 9. | Jacobs, J. A., E. I. De Brauwer, G. Ramsay, N. A. Cobben, S. S. Wagenaar, A. J. van der Ven, C. A. Bruggeman, and M. Drent. 1999. Detection of non-infectious conditions mimicking pneumonia in the intensive care setting: usefulness of bronchoalveolar fluid cytology. Respir. Med. 93:571-578[CrossRef][Medline]. |
| 10. | Jalava, K. M., K. T. Olkkola, and P. J. Neuvonen. 1997. Itraconazole greatly increases plasma concentrations and effects of felodipine. Clin. Pharmacol. Ther. 61:410-415[CrossRef][Medline]. |
| 11. | Kwon-Chung, K. J., and J. E. Bennett. 1992. Phaeohyphomycosis, p. 620-677. In K. J. Kwon-Chung, and J. E. Bennett (ed.), Medical mycology. Lea & Febiger, Philadelphia, Pa. |
| 12. | Laumaillé, C., F. Le Gall, B. Degeilh, E. Gueho, and M. Huerre. 1998. Cutaneous Alternaria infectoria infection after liver transplantation. Ann. Pathol. 18:192-194[Medline]. |
| 13. | McGinnis, M. R. 1983. Chromoblastomycosis and phaeohyphomycosis: new concepts, diagnosis, and mycology. J. Am Acad. Dermatol. 8:1-16[Medline]. |
| 14. | Morrison, V. A., R. J. Haake, and D. J. Weisdorf. 1993. The spectrum of non-Candida fungal infections following bone marrow transplantation. Medicine 72:78-89[Medline]. |
| 15. | Ramos, A. M., A. de O. Sales, M. C. de Andrade, J. F. Bittencourt, and C. C. Ramos. 1995. A simple method for detecting subcutaneous phaeohyphomycosis with light-colored fungi. A study of eight cases. Am. J. Surg. Pathol. 19:109-114[Medline]. |
| 16. | Rees, J. R., R. W. Pinner, R. A. Hajjeh, M. E. Brandt, and A. L. Reingold. 1998. The epidemiological features of invasive mycotic infections in the San Francisco Bay area, 1992-1993: results of population-based laboratory active surveillance. Clin. Infect. Dis. 27:1138-1147[Medline]. |
| 17. | Rinaldi, M. G. 1996. Phaeohyphomycosis. Dermatol. Clin. 14:147-153[CrossRef][Medline]. |
| 18. | Roosje, P. J., G. S. de Hoog, J. P. Koeman, and T. Willemse. 1993. Phaeohyphomycosis in a cat caused by Alternaria infectoria E. G. Simmons. Mycoses 36:451-454. |
| 19. | Rosen, T. 1994. Debilitating edema associated with itraconazole therapy. Arch. Dermatol. 130:260-261[CrossRef][Medline]. |
| 20. | Schell, W. A. 1995. New aspects of emerging fungal pathogens. Clin. Lab. Med. 15:365-387[Medline]. |
| 21. | Sharkey, P. K., J. R. Graybill, M. G. Rinaldi, D. A. Stevens, R. M. Tucker, J. D. Peterie, P. D. Hoeprich, D. L. Greer, L. Frenkel, G. W. Counts, et al. 1990. Itraconazole treatment of phaeohyphomycosis. J. Am. Acad. Dermatol. 23:577-586[Medline]. |
| 22. | Simmons, E. G. 1986. Alternaria themes and variations (22-26). Mycotaxon 25:287-308. |
| 23. | Simmons, E. G. 1993. Alternaria themes and variations (73). Mycotaxon 48:109-140. |
| 24. | Simmons, E. G. 1994. Alternaria themes and variations (106-111). Mycotaxon 50:409-427. |
| 25. | Vartivarian, S. H., E. L. Anaissie, and G. P. Bodey. 1993. Emerging fungal pathogens in immunocompromised patients: classification, diagnosis, and management. Clin. Infect. Dis. 17:S487-S491. |
| 26. | Ziefer, A., and D. H. Connor. 1980. Phaeomycotic cyst. A clinicopathologic study of twenty-five patients. Am. J. Trop. Med. Hyg. 29:901-911. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|